by Madaline Spencer | Apr 23, 2025
Sindhu Ramchandren, MD, Executive Medical Director, Neuroscience and Disease Cluster Lead for Neuroimmunology and Neuromuscular Disorders at Johnson & Johnson, discusses updated results from the Vivacity-MG3 clinical trial in patients with generalized myasthenia...
by Madaline Spencer | Apr 22, 2025
A recent study published in Liver International analyzed patients with primary biliary cholangitis (PBC) who presented with higher IgG levels at diagnosis. Primary Biliary Cholangitis PBC is a chronic, progressive liver disease in which the bile ducts become...
by Madaline Spencer | Apr 21, 2025
Michael Weiss, MD, Department of Neurology, University of Washington Medical Center, discusses results from the RAISE clinical trial testing the safety and efficacy of zilucoplan in patients with myasthenia gravis (MG). MG is a chronic autoimmune...
by Madaline Spencer | Apr 18, 2025
Richard Lafayette, MD, Professor of Medicine, Nephrology and Director of the Glomerular Disease Center at Stanford University Medical Center, discusses the recent approval of Vanrafia (atrasentan) for patients with IgA nephropathy (IgAN). IgAN is a rare...
by Madaline Spencer | Apr 17, 2025
A recent study published in The Journal of Clinical Endocrinology & Metabolism analyzed the use of digital voice analysis as a biomarker of acromegaly. Acromegaly is an endocrine disorder resulting from the overproduction of growth hormone in the pituitary gland....
